Literature DB >> 16079162

The sensitivity and specificity of markers for event times.

Tianxi Cai1, Margaret Sullivan Pepe, Yingye Zheng, Thomas Lumley, Nancy Swords Jenny.   

Abstract

The statistical literature on assessing the accuracy of risk factors or disease markers as diagnostic tests deals almost exclusively with settings where the test, Y, is measured concurrently with disease status D. In practice, however, disease status may vary over time and there is often a time lag between when the marker is measured and the occurrence of disease. One example concerns the Framingham risk score (FR-score) as a marker for the future risk of cardiovascular events, events that occur after the score is ascertained. To evaluate such a marker, one needs to take the time lag into account since the predictive accuracy may be higher when the marker is measured closer to the time of disease occurrence. We therefore consider inference for sensitivity and specificity functions that are defined as functions of time. Semiparametric regression models are proposed. Data from a cohort study are used to estimate model parameters. One issue that arises in practice is that event times may be censored. In this research, we extend in several respects the work by Leisenring et al. (1997) that dealt only with parametric models for binary tests and uncensored data. We propose semiparametric models that accommodate continuous tests and censoring. Asymptotic distribution theory for parameter estimates is developed and procedures for making statistical inference are evaluated with simulation studies. We illustrate our methods with data from the Cardiovascular Health Study, relating the FR-score measured at enrollment to subsequent risk of cardiovascular events.

Mesh:

Substances:

Year:  2005        PMID: 16079162     DOI: 10.1093/biostatistics/kxi047

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  22 in total

1.  Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.

Authors:  Le Kang; Weijie Chen; Nicholas A Petrick; Brandon D Gallas
Journal:  Stat Med       Date:  2014-11-17       Impact factor: 2.373

2.  Evaluating the ROC performance of markers for future events.

Authors:  Margaret S Pepe; Yingye Zheng; Yuying Jin; Ying Huang; Chirag R Parikh; Wayne C Levy
Journal:  Lifetime Data Anal       Date:  2007-12-07       Impact factor: 1.588

3.  Efficient resampling methods for nonsmooth estimating functions.

Authors:  Donglin Zeng; D Y Lin
Journal:  Biostatistics       Date:  2007-10-08       Impact factor: 5.899

4.  Robust prediction of t-year survival with data from multiple studies.

Authors:  Tianxi Cai; Thomas A Gerds; Yingye Zheng; Jinbo Chen
Journal:  Biometrics       Date:  2010-07-28       Impact factor: 2.571

5.  On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Authors:  Hajime Uno; Tianxi Cai; Michael J Pencina; Ralph B D'Agostino; L J Wei
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

6.  Comparison of two correlated ROC curves at a given specificity or sensitivity level.

Authors:  Leonidas E Bantis; Ziding Feng
Journal:  Stat Med       Date:  2016-06-20       Impact factor: 2.373

7.  A direct method to evaluate the time-dependent predictive accuracy for biomarkers.

Authors:  Weining Shen; Jing Ning; Ying Yuan
Journal:  Biometrics       Date:  2015-03-10       Impact factor: 2.571

8.  Landmark risk prediction of residual life for breast cancer survival.

Authors:  Layla Parast; Tianxi Cai
Journal:  Stat Med       Date:  2013-03-14       Impact factor: 2.373

9.  Non-parametric Evaluation of Biomarker Accuracy under Nested Case-control Studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  J Am Stat Assoc       Date:  2012-01-24       Impact factor: 5.033

10.  Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.

Authors:  Michael A Marchetti; Daniel G Coit; Stephen W Dusza; Ashley Yu; LaToya McLean; Yinin Hu; Japbani K Nanda; Konstantina Matsoukas; Silvia E Mancebo; Edmund K Bartlett
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.